BIBLIOGRAFÍA

1. Morris S, Jardine A. The vascular endothelium in chronic renal failure. J Nephrol 2000; 13 (2) :1-16

2. Orida N K, Ching - Sang L: Nitric Oxide and the Renal Patient. Dialysis & Transplantation 2000; 29 (4): 174-187

3. Kohan DE: Endothelins in the Normal and Diseased Kidney. Am J Kidney Dis 1997; 29(1): 2-26

4. Kone BC: Localization and regulation of nitric oxide synthasa isoforms in the kidney. Semin Nephrol 1999; 19: 230-241

5. Morrissey JJ, McCracken R, Kaneto H et al: Localization of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994; 45: 1593-1601

6. Furusu A, Miyasaki M, Abe K et al: Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53: 1760-1768

7. Goligorsky MS, Noiri E: Duality of nitric oxide in acute renal injury. Semin Nephrol 1999; 19: 263-271

8. Brown M, Shyan-Ying C, Porush J: Endothelins and Kidney Diseases. Nephron 1996; 72: 375-382

9. Shyan-Ying C, Porush J: Renal Actions of Endothelin-1 and Endothelin-3: Interactions With the Prostaglandin System and Nitric Oxide. Am J Kidney Dis1995; 26(1): 116-123

10. Lahera V, de la Heras N, Vediel E et al: Fisiopatología de la disfunción endotelial asociada a la HTA. Cardiol. Día 2000; 3(1): 19-26

11. Adam A, Raij L: Nitric Oxide Angiotensin II axis in renal and cardiovascular injury. J Nephrol 2000; 13: 211-220

12. Manns B.J.: Hyperhocysteinemia and the prevalence of atherosclerotic vascular disease in patients with end - stage renal disease. Am J Kidney Dis 1999; 34:669-677

13. Guido MC: Homocisteína en Enfermedad vascular. Rev Nefrol Dial y Transpl 2000; 51: 37-39

14. Arese M, Strasly M, Ruva C et al: Regulation of nitric oxide synthesis in uremia. Nephrol Dial Transplant 1995; 10: 1386-97

15. Aznar-Salatti J, Escolar G, Cases A et al: Uraemic medium causes endothelial dysfunction characterized by an alteration of the properties of its subendothelial matrix. Nephrol Dial Transplant 1995; 10: 2199-204

16. Joannides R, Bakkali EH, Le Roy F et al: Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 1997; 12: 2623-8

17. Amore A, Bonaudo R, Ghigo D et al: Enhanced production of nitric oxide by blood dialysis membrane interaction. J Am Soc Nephrol 1995; 6: 1278-1283

18. Schmidt RJ, Dominco J, Samsell LS et al: Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis 1999; 34: 228-234

19. Dickinson E, Tuncer R, Nadler E et al: NOX, a novel nitric oxide scavenger, reduces bacterial translocations in rats after endotoxin challenge. Am J Physiol 1999; 277: G 1281-G1287

20. Bloembergen WE, Hakim R, Stannard BA et al: Relationship of Dialysis Membrane and Cause-Specific Mortality. Am J Kidney Dis 1999; 33(1): 1-10

21. Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213-219

22. Sowers J R and Izzo J: Endothelial Dysfunction. In Joseph L. Izzo and Henry Black (ed). HYPERTENSION PRIMER. Second edition. 1999; pp: 167-169

23. Benigni A: Endothelin antagonists in renal disease. Kidney Int 2000; 57: 1778-1794

24. Egido J: Vasoactive hormones and renal sclerosis. Kidney Int 1996; 49: 578-597

25. Bianchi S, Bigazzi R, Campese V: Microalbuminuria in Essential Hypertension: Significance, Pathophysiology, and Therapeutic Implications. Am J Kidney Dis 1999; 34(6): 973-995

26. Pedrinelli R, Gianpietro O, Carmassi F et al: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18

27. Klahr S: Can L-arginine manipulation reduce renal disease? Semin Nephrol 1999;19: 304-309

28. Rudnick M, Berns J, Cohen R et al: Contrast Media-Associated Nephrotoxicity. Semin Nephrol 1997; 17(1): 15-26

29. Bakris G, Lass N, Glock D: Renal Hemodynamics in Radiocontrast Medium-Induced Renal Dysfunction: A role for Dopamine - 1 Receptors. Kidney Int 1999; 56: 206-210

30. Hricik D, Chung-Park M, Sedor J: Glomerulonephritis. N Engl J Med 1998; 339(13): 888-899

31. Epstein F: Pathophysiology of Progressive Nephropathies.N Engl J Med 1998; 339 (20): 1448-1456

32. Couser W: Glomerulonephritis. Lancet 1999; 353: 1509-1515

33. Detlef S and Segerer S: Pathogenesis of glomerulonephritis, a perspective from the last 30 years. J Nephrol 1999; 12 (suppl 2): S131-S141

34. Zoja C, Donadelli R, Corna D et al: The Renoprotective Properties of Angiotensin-Converting Enzyme Inhibitors in a Chronic Model of Membranous Nephropathy Are Solely Due to the Inhibition of Angiotensin II: Evidence Based on Comparative studies With a Receptor Antagonist. Am J Kidney Dis 1997; 29(2): 254-264

35. Diaz P and Amorena C:Rol del óxido nítrico y el shear stress en el proceso de acidificación proximal: un mecanismo propuesto de acople entre la reabsorción proximal de sodio y la carga filtrada. Rev Nefrol Dial y Transpl 2000; 52: 3-12

36. Haynes WG and Webb D: Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998; 16: 1081-1098

37. Hillebrands J L, Nieuwenhuis P and Rozing J: The Origin of Vascular Smooth Muscle Cells and Endothelium in Transplant Arteriosclerosis. Graft 2000; 3(4): 205-211

38. Burnier M and Brunner H: Angiotensin II Receptor Antagonists in Hypertension. Kidney Int 1998; 54 (suppl 68): S107-S111

39. Taal M and Brenner B: Renoprotective Benefits of RAS Inhibition: From ACEI to Angiotensin II Antagonists. Kidney Int 2000; 57: 1803-181

40. Watschinger B, Sayegh M: Endothelin in Organ Transplantation. Am J Kidney Dis 1996; 27(1): 151-161

41. Gudmundsdottir H and Turka L: Transplantation Tolerance: Mechanisms and Strategies?. Semin Nephol 2000: 20(2): 209-216

42. Strom T and Suthanthiran: Prospects and Applicability of Molecular Diagnosis of Allograft Rejection. Semin Nephrol 2000: 20(2): 103-107

43. Bernheim J: Hypertension in Pregnancy. Nephron 1997; 76: 254-263

44. Sibal B: Treatment of Hypertension in Pregnant Women. N Engl J Med 1996; 335(4): 257 -265

45. Coelho E, Ballejo G, Salgado MC: Nitric Oxide Blunts Sympathetic Response of Pregnant Normotensive and Hypertensive Rat Arteries. Hypertension 1997; 30 (part 2): 585-588

46. Bobadilla A, Castillo C, Castillo E et al: Possible involvement of Endothelium-Derived Hyperpolarizing Factor in Vascular Responses of Abdominal Aorta From Pregnant Rats. Hypertension 1997( part 2): 596-602

47. Ruggenenti P, Remuzzi G: Malignant Vascular Disease of the Kidney. Am J Kidney Dis 1996; 27(4): 459-475

48. Tepel M, Van der Giet M, Schwarzfeld C et al: Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine. N Engl J Med 2000; 343(3): 180-184

49. Safirstein R, Andrade L, Vieira J: Acetylcysteine and Nephrotoxic Effects of Radiographic Contrast Agents-A New Use for an Old Drug. N Engl J Med 2000; 343(3): 210-212

50. O'Leary M, Bihari D: Preventing Renal Failure in the Critically ill. BMJ 2001; 322: 1437-1439